These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11721153)

  • 1. The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients.
    Borawski J; Myśliwiec M
    Nephron; 2001 Dec; 89(4):381-3. PubMed ID: 11721153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.
    Gunnell J; Yeun JY; Depner TA; Kaysen GA
    Am J Kidney Dis; 1999 Jan; 33(1):63-72. PubMed ID: 9915269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty.
    Ghanem E; Antoci V; Pulido L; Joshi A; Hozack W; Parvizi J
    Int J Infect Dis; 2009 Nov; 13(6):e444-9. PubMed ID: 19473865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte sedimentation rate in stable patients on chronic hemodiaysis.
    Alsomaili MI; Yousuf M; Hejaili F; Almotairi W; Al-Sayyari AA
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1149-53. PubMed ID: 26586052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical observation of extremely elevated erythrocyte sedimentation rate].
    Xu W; Zhao W; Qian R; Xiao-Li L; Wang Y; Dai D; Zhu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):613-617. PubMed ID: 34112304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma ESR: an erythrocyte sedimentation rate adjusted for the hematocrit and hemoglobin concentration.
    Pawlotsky Y; Goasguen J; Guggenbuhl P; Veillard E; Jard C; Pouchard M; Perdriger A; Meadeb J; Chalès G
    Am J Clin Pathol; 2004 Nov; 122(5):802-10. PubMed ID: 15491977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of C-reactive protein in comparison with erythrocyte sedimentation as routine admission diagnostic test].
    Buess T; Ludwig C
    Schweiz Med Wochenschr; 1995 Jan; 125(4):120-4. PubMed ID: 7878400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test-1 analyzer and conventional Westergren method for erythrocyte sedimentation rate: A comparative study between two laboratories.
    Sonmez C; Dogan OC; Kaymak AO; Akkaya N; Akin KO; Guntas G
    J Clin Lab Anal; 2018 Jun; 32(5):e22384. PubMed ID: 29341286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Ves-Matic Cube 200 erythrocyte sedimentation method: comparison with Westergren-based methods.
    Curvers J; Kooren J; Laan M; van Lierop E; van de Kerkhof D; Scharnhorst V; Herruer M
    Am J Clin Pathol; 2010 Oct; 134(4):653-60. PubMed ID: 20855647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice.
    Colombet I; Pouchot J; Kronz V; Hanras X; Capron L; Durieux P; Wyplosz B
    Am J Med; 2010 Sep; 123(9):863.e7-13. PubMed ID: 20800157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory markers as mortality predictors in continuous ambulatory peritoneal dialysis patients.
    Jovanovic DB; Stosović MD; Gojakovic BM; Jovanovic NZ; Stanojevic-Stosovic MLj; Simic-Ogrizovic SP; Naumovic RT
    Ren Fail; 2015 Mar; 37(2):230-6. PubMed ID: 25394528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESR or CRP? A comparison of their clinical utility.
    Osei-Bimpong A; Meek JH; Lewis SM
    Hematology; 2007 Aug; 12(4):353-7. PubMed ID: 17654065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erythrocyte sedimentation rate, C-reactive protein, plasma fibrinogen and viscosity in chronic renal disease patients with infection.
    Ishak R; Hassan K
    Malays J Pathol; 1989 Aug; 11():29-31. PubMed ID: 2632997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte sedimentation rate in elderly blacks.
    Bester FC; Weich DJ; Badenhorst PN; de Wet JI
    S Afr Med J; 1993 Jul; 83(7):498-500. PubMed ID: 8211489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis.
    Zumrutdal A; Sezer S; Demircan S; Seydaoglu G; Ozdemir FN; Haberal M
    Nephrology (Carlton); 2005 Oct; 10(5):453-8. PubMed ID: 16221094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevant detection indicator of prethrombotic state in patients with primary hypertension.
    Luo J; Yang T; Ding L; Xiong JH; Ying T; Xu F
    World J Clin Cases; 2023 Aug; 11(24):5678-5691. PubMed ID: 37727711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
    J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance.
    Costenbader KH; Chibnik LB; Schur PH
    Clin Exp Rheumatol; 2007; 25(5):746-9. PubMed ID: 18078625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.
    Crowson CS; Rahman MU; Matteson EL
    J Rheumatol; 2009 Aug; 36(8):1606-10. PubMed ID: 19531760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.